PB2 inhibited the expression and nuclear translocation of PKM2, thereby disrupting the interaction between PKM2/HSP90/HIF-1α, and inhibiting the aerobic glycolysis and proliferation of liver cancer cells (Feng et al., 2019). The gene discussed is HIF1A; the disease is liver cancer.